Assessment of the Efficacy of the Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Daily Headache in Children and Adolescents.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Primary Objective The primary objective of the study is to assess whether transnasal sphenopalatine ganglion block using the device TX360 reduces intensity and severity of the Post-Traumatic Headache in adolescents. Secondary Objectives The study will also evaluate: * Quality of life (QoL) * Intensity of the headache * Physical function * Sleep quality * Role function (measured by PEDMIDAS) * Adverse events
Epistemonikos ID: d2f7e983bde02b3d9e88cb9dc7356d5488aefd41
First added on: May 10, 2024